Cargando…
Has Convalescent Plasma Therapy Hesitancy Increased COVID-19 Mortality?
We bring to you our viewpoint and a snapshot of the journey of convalescent plasma therapy (CPT) in the management of ongoing coronavirus disease 2019 (COVID-19) pandemic. We also discuss how best to use the updated data on this important treatment option and maximize benefit for our patients, there...
Autores principales: | Parikh, Purvish M., Sood, T., Agarwala, V., Kate, S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Thieme Medical and Scientific Publishers Private Ltd
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380149/ https://www.ncbi.nlm.nih.gov/pubmed/34430518 http://dx.doi.org/10.1055/s-0041-1733351 |
Ejemplares similares
-
Convalescent Plasma Use in the United States was inversely correlated with COVID-19 Mortality: Did Plasma Hesitancy cost lives?
por: Casadevall, Arturo, et al.
Publicado: (2021) -
Predictors of mortality in COVID-19 patients treated with convalescent plasma therapy
por: Rahimi-Levene, Naomi, et al.
Publicado: (2022) -
Convalescent plasma therapy in COVID 19: Every dark cloud has a silver lining
por: Deokar, Kunal, et al.
Publicado: (2020) -
Retraction: Convalescent plasma therapy in COVID 19: Every dark cloud has a silver lining
Publicado: (2020) -
Convalescent plasma therapy in patients with COVID-19
por: Altuntas, Fevzi, et al.
Publicado: (2021)